Prospective, Randomized Clincal Trial Comparing the Efficacy of Two Vaccines Against Hepatis B Virus (HBV) in Inflamatory Bowel Disease (IBD) Patients

被引：0
|
作者：
Chaparro, Maria
Gordillo, Jordi
Domenech, Eugeni
Esteve, Maria
Acosta, Manuel Barreiro-de
Villoria, Albert
Flores, Eva Iglesias
Blasi, Mercedes
Naves, Juan E.
Benitez, Olga
Nieto, Laura
Calvet, Xavier
Garcia-Sanchez, Valle
Villagrasa, Jose R.
Marin, Alicia C.
Ramas, Mercedes
Moreno, Isabel
Gisbert, Javier P.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1267
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 34 条
  • [21] Prospective, single-blinded, single-center randomized controlled trial comparing outcomes of bowel preparation for colonoscopy using MoviPrep or Prepkit-C in patients with or without inflammatory bowel disease
    Mohsen, W.
    Wark, G.
    Greenup, A.
    Sechi, A.
    Sawyer, E.
    Koo, J. H.
    Ng, W.
    Connor, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 25 - 25
  • [22] Comparison Between Sci-B-Vac™ (Third Generation Vaccine) and Engerix-B Vaccines for Hepatitis B Virus in Patients With Inflammatory Bowel Diseases Treated With Immunosuppressive Medications. Randomized Control Trial
    Etzion, Ohad
    Novack, Victor
    Perl, Yael
    Abel, Olga
    Schwartz, Doron
    Abufreha, Naim
    Munteanu, Daniela
    Ben-Yakov, Gil S.
    Fich, Alexander
    GASTROENTEROLOGY, 2015, 148 (04) : S269 - S269
  • [23] E.A.E.S. multicenter prospective randomized trial comparing two-stage vs single-stage management of patients with gallstone disease and ductal calculi
    A. Cuschieri
    E. Lezoche
    M. Morino
    E. Croce
    A. Lacy
    J. Toouli
    A. Faggioni
    V. M. Ribeiro
    J. Jakimowicz
    J. Visa
    G. B. Hanna
    Surgical Endoscopy, 1999, 13 : 952 - 957
  • [24] Rationale and design of a phase 3b, prospective, randomized, open label, blinded-endpoint, multicenter trial of the efficacy and safety of urokinase thrombolysis comparing with antiplatelet agents for patients with minor stroke
    Zhao, Lu
    Jiang, Chenyang
    Tao, Yongli
    Gao, Yuan
    Xu, Yafang
    Zhang, Rui
    Liu, Kai
    Gu, Hongqiu
    Wang, Yilong
    Xu, Yuming
    Song, Bo
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (04) : 474 - 477
  • [25] Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)
    Shinji Ohno
    Shigehira Saji
    Norikazu Masuda
    Hitoshi Tsuda
    Futoshi Akiyama
    Masafumi Kurosumi
    Akihiko Shimomura
    Nobuaki Sato
    Shintaro Takao
    Shozo Ohsumi
    Yutaka Tokuda
    Hideo Inaji
    Toru Watanabe
    Yasuo Ohashi
    Breast Cancer Research and Treatment, 2021, 186 : 135 - 147
  • [26] Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N•SAS-BC 01 trial and CUBC trial)
    Ohno, Shinji
    Saji, Shigehira
    Masuda, Norikazu
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Kurosumi, Masafumi
    Shimomura, Akihiko
    Sato, Nobuaki
    Takao, Shintaro
    Ohsumi, Shozo
    Tokuda, Yutaka
    Inaji, Hideo
    Watanabe, Toru
    Ohashi, Yasuo
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 135 - 147
  • [27] Hepatitis B virus (HBV) infected end stage renal disease (ESRD) patients on maintenance hemodialysis (HD): A randomized double blind placebo controlled clinical trial with a polyherbal formulation - New LivFit (NLF)
    Nandi, AR
    Dutta, A
    Jain, AK
    Katiyar, CK
    Srivastava, S
    Misra, RP
    Mehrotra, R
    JOURNAL OF HEPATOLOGY, 2002, 36 : 239 - 239
  • [28] A 24-Week, Parallel-Group, Open-Label, Randomized Clinical Trial Comparing the Early Antiviral Efficacy of Telbivudine and Entecavir in the Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis B Virus Infection in Adult Chinese Patients
    Zheng, Ming-Hua
    Shi, Ke-Qing
    Dai, Zhi-Juan
    Ye, Chao
    Chen, Yong-Ping
    CLINICAL THERAPEUTICS, 2010, 32 (04) : 649 - 658
  • [29] Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting
    Cannon, Christopher P.
    Gropper, Savion
    Bhatt, Deepak L.
    Ellis, Stephen G.
    Kimura, Takeshi
    Lip, Gregory Y. H.
    Steg, Ph. Gabriel
    ten Berg, Jurrien M.
    Manassie, Jenny
    Kreuzer, Jorg
    Blatchford, Jon
    Massaro, Joseph M.
    Brueckmann, Martina
    Ripoll, Ernesto Ferreiros
    Oldgren, Jonas
    Hohnloser, Stefan H.
    CLINICAL CARDIOLOGY, 2016, 39 (10) : 555 - 564
  • [30] Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial
    Hill, Nathan R.
    Lasserson, Daniel
    Thompson, Ben
    Perera-Salazar, Rafael
    Wolstenholme, Jane
    Bower, Peter
    Blakeman, Thomas
    Fitzmaurice, David
    Little, Paul
    Feder, Gene
    Qureshi, Nadeem
    Taal, Maarten
    Townend, Jonathan
    Ferro, Charles
    McManus, Richard
    Hobbs, F. D. Richard
    TRIALS, 2014, 15 (01)
1234